Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · N16895/S107

Bausch & Lomb SofLens (polymacon) Contact Lenses

Bausch + Lomb, Inc. · Decision date Oct 24, 2025

FDA DECISIONN16895/S107

What did the FDA decide?

FDA records N16895/S107 as a supplement to PMA null, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 24, 2025.

FDA approval order statement

use of a New Technology Moulding Machine in the Reverse Process III (RPIII) manufacturing process utilized in the Bausch + Lomb Waterford, Ireland manufacturing facility
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Ophthalmic
Decision date
Oct 24, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
N16895/S107
Regulatory pathway
PMA supplement
Product code
LPM
Decision code
OK30
Decision date
Oct 24, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Lenses, soft contact, extended wear.

Product code
LPM
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. N16895/S107 received

    Application receipt date recorded by FDA.

  2. N16895/S107 · FDA decision

    30-Day Notice

Related devices and submissions

Explore the linked device profile

Other records with product code LPM

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Bausch + Lomb, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1400 N. Goodman St., Rochester, NY, 14609

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records